The Thomson Message Mapping System (TMMS) was formerly called the Astrolabe Message Mapping System. TMMS measures the impact of pharmaceutical product messaging on the attitudes and product knowledge of prescribing clinicians. To do this, TMMS utilizes a process by which the key ideas and messages published about a product in journal articles, abstracts, monographs, posters, and more, are identified, categorized, and quantitatively scored from the point of view of the practicing clinician.

Are your drug messages really having a positive impact? TMMS helps you to see your drug messaging through the eyes of the clinician.